.png)
Building Human-Relevant Immuno Oncology Models: A Conversation With Ncardia’s Sanne Holt
Driving Predictive Science Forward: Inside the Shift Toward Human-Relevant Drug Discovery
Ncardia Acquires STAR-CRISPR Technology for Advanced Gene Editing of iPSCs
Unveiling Ncardia's Path to Innovation and Growth
.png)
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Press release: Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
